Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA.
Home » Archives for Raina Naidoo
Categories
Categories
Top Posts
- Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA.
- RBFOX2 Modulates a Metastatic Signature of Alternative Splicing in Pancreatic Cancer
- Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
- A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer
- Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Top Posts
- Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA.
- RBFOX2 Modulates a Metastatic Signature of Alternative Splicing in Pancreatic Cancer
- Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
- A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer
- Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression